Lang James Paul
CIK 0001703090
Director
Filings
16
Latest May 7, 2026
Issuers covered
3
Showing
16 of 16
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +7.2% | +7.2% | +7.2% | +7.2% |
| 90 days | 1 | 100% | +93.7% | +93.7% | +93.7% | +93.7% |
| 180 days | 1 | 100% | +126.0% | +126.0% | +126.0% | +126.0% |
| 365 days | 1 | 0% | -16.0% | -16.0% | -16.0% | -16.0% |
Issuers
Companies where Lang James Paul has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| OPRX | Optimizerx Corp | 9 | Jun 12, 2025 |
| BIVI | Biovie Inc. | 5 | Jan 9, 2026 |
| HALO | Halozyme Therapeutics, Inc. | 2 | May 7, 2026 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|